imidazole has been researched along with Cognition Disorders in 2 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babizhayev, MA | 1 |
| Brown, JW | 1 |
| Whitehead, CA | 1 |
| Basso, AM | 1 |
| Rueter, LE | 1 |
| Zhang, M | 1 |
1 review available for imidazole and Cognition Disorders
| Article | Year |
|---|---|
Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology
Topics: Animals; Cognition Disorders; Depression; Depressive Disorder; Dipeptides; Humans; Imidazoles; Intel | 2014 |
1 other study available for imidazole and Cognition Disorders
| Article | Year |
|---|---|
Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Cognition Disorders; Drug Evaluation, Preclinical | 2013 |